Atlas Trials

Safety Study of Intranasal Insulin in Type 1 Diabetes and Diabetic Peripheral Neuropathy

Clinical trial NCT01469559 · COMPLETED

Trial details

NCT number
NCT01469559
Sponsor
University of Calgary
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Diabetic Peripheral Neuropathy
Start date
2011-08-01
Primary completion
2012-07-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.